Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737340) titled 'Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)' on July 27.
Study Type: Observational [Patient Registry]
Primary Sponsor: Yasar Bayindir, MD
Condition:
HIV Infections
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)
Fatty Liver
Intervention:
Diagnostic Test: FibroScan (Transient Elastography)
Diagnostic Test: Hepatobiliary Ultrasonography (USG)
Recruitment Status: Recruiting
Date of First Enrollment: June 1, 2024
Target Sample Size: 411
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT0...